The Comparison of the aging male symptoms (AMS) scale and androgen deficiency in the aging male (ADAM) questionnaire to detect androgen deficiency in middle-aged men

Journal of Andrology

Volumn 33, Issue 5, 2012, Pages 817-823

  Chueh, Kuang Shun ^a   Huang, Shu Pin ^a,b   Lee, Yung Chin ^a,b,c   Wang, Chii Jye ^a,b   Yeh, Hsin Chih ^a,c,d   Li, Wei Ming ^a,c,e   Wu, Wen Jeng ^a,b,f   Tsai, Yueh Fong ^a   Tsai, Chia Chun ^a,d   Juan, Hsu Cheng ^a   Huang, Chun Hsiung ^a,b   Liu, Chia Chu ^a,b,c,e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^e Pingtung Hospital   (Taiwan)

^f KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

ADAM questionnaire; AMS scale; Testosterone

Indexed keywords

ALBUMIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; AGED; AGING MALE SYMPTOMS SCALE; ANDROGEN DEFICIENCY; ANDROGEN DEFICIENCY IN THE AGING MALE QUESTIONNAIRE; ARTICLE; BLOOD SAMPLING; HUMAN; MALE; MASS SCREENING; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TAIWAN; TESTOSTERONE BLOOD LEVEL; AGE; AGING; ANDROPAUSE; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; PREDICTIVE VALUE; QUESTIONNAIRE;

AGE FACTORS; AGED; AGING; ANDROPAUSE; BIOLOGICAL MARKERS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SEX HORMONE-BINDING GLOBULIN; TAIWAN; TESTOSTERONE;

EID: 84872228554     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.111.015628     Document Type: Article

References (35)

1. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92: 4241-4247.
2. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:1995-2010.
3. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-2559.
4. Chen CY, Wang WS, Liu CY, Lee SH. Reliability and validation of a Chinese version of the Aging Males' Symptoms scale. Psychol Rep. 2007;101:27-38.
5. Chu LW, Tam S, Kung AW, Lam TP, Lee A, Wong RL, Lo S, Fan S, Chung CP, Morley JE, Lam KS. A short version of the ADAM Questionnaire for androgen deficiency in Chinese men. J Gerontol A Biol Sci Med Sci. 2008;63:426-431.
6. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. J Am Med Assoc. 2006;295:1288-1299.
7. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589-598.
8. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724-731.
9. Heinemann L, Zimmermann T, Vermeulen A, Thiel C. A new "Aging Male's Symptoms"(AMS) rating scale. Aging Male. 1999;2:105-114.
10. Heinemann LA, Saad F, Heinemann K, Thai DM. Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency? Aging Male. 2004;7:211-218.
11. Hwang TI, Lin YC. The relationship between hypogonadism and erectile dysfunction. Int J Impot Res. 2008;20:231-235.
12. Isidori AM, Giannetta E, Pozza C, Bonifacio V, Isidori A. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Invest. 2005;28:73-79.
13. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation. 2007;116:2694-2701.
14. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27:1036-1041.
15. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008;93: 68-75.
16. Liu CC, Huang SP, Li WM, Wang CJ, Chou YH, Li CC, Huang CH, Wu WJ. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology. 2007;70:677-680.
17. Liu CC, Wu WJ, Lee YC, Wang CJ, Ke HL, Li WM, Hsiao HL, Yeh HC, Li CC, Chou YH, Huang CH, Huang SP. The prevalence of and risk factors for androgen deficiency in aging Taiwanese men. J Sex Med. 2009;6:936-946.
18. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K. The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med. 2007;4:1056-1069.
19. Maggio M, Basaria S. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res. 2009;21:261-264.
20. Martinez-Jabaloyas JM, Queipo-Zaragoza A, Rodriguez-Navarro R, Queipo-Zaragoza JA, Gil-Salom M, Chuan-Nuez P. Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age. Eur Urol. 2007;52:1760-1767.
21. Morales A, Spevack M, Emerson L, Kuzmarov I, Casey R, Black A, Tremblay R. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male. 2007;10:57-65.
22. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, PerryHM3rd. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49:1239-1242.
23. Morley JE, Perry HM 3rd, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas. 2006;53:424-429.
24. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60:762-769.
25. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol. 2005;48:1-4.
26. Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, Cauley J, EnsrudK, Cummings S. Testosterone and estradiol among older men. J Clin Endocrinol Metab. 2006;91:1336-1344.
27. Tancredi A, Reginster JY, Schleich F, Pire G, Maassen P, Luyckx F, Legros JJ. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol. 2004;151:355-360.
28. Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl. 2009a;30:10-22.
29. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl. 2009b;30:477-494.
30. Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl. 2009c;30:23-32.
31. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007; 92:549-555.
32. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
33. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi IT. Identification of lateonset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123-135.
34. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D. Hypothalamicpituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93:2737-2745.
35. Yoshida NM, Kumano H, Kuboki T. Does the Aging Males' Symptoms scale assess major depressive disorder?: a pilot study. Maturitas. 2006;53:171-175